What is The Swine Influenza Vaccine and Can it Really Prevent The Spread of Swine Influenza

Posted by admin on August 13, 2009 under Swine Flu Vaccine Information | Comments are off for this article

In 2009, the global community was struck by one of the worst epidemics in history.  A disease so viral its spread is virtually impossible to contain and manage.  The Swine Influenza epidemic of 2009 has now achieved a pandemic status.  The first time something like this has happened in the last four decades.

The WHO and many disease control organizations across the globe are scurrying to protect us from this new viral disease.  They are doing this by promoting preventative measures as well as unprecedented cooperation in developing a vaccine. However we must first educate ourselves of what a swine influenza vaccine really is and if there are any serious dangers from the swine influenza vaccine itself.

The development of a swine influenza vaccine is a long and tedious process which can only be undertaken by only a handful of pharmaceutical companies.  The vaccine development process is quite intricate; they utilize various bits of several different flu viruses to construct a vaccine which specifically stimulates the body’s own immune system against the Swine Influenza Virus.  The reason for using bits of the virus is because it would be the only way to generate sufficient quantities of the vaccine (the bits of viruses are actually grown in hen eggs).  After the viruses are extracted from the hen eggs, they are broken down into smaller pieces which ensure the protein coat of the virus is exposed so that it can induce an auto-immune response in humans.

Antibodies are then formed in the blood as a direct response to the external protein particles.  These are the particles that best resemble those of the swine flu virus.  Therefore the vaccine actually loads the immune system full of antibodies which will attack the swine flu virus should a person contract it.

The problem with the swine influenza vaccine is that manufactures such as Glaxo Smithkline who makes both the Tamiflu (oseltamivir) and Relenza (zanamivir) swine influenza vaccines is the sheer quantities that are required in order to meet demand.  In order to produce enough vaccines chemical agents called adjuvants will have to be added to the vaccine mix.  Adjuvants are used to stimulate the immune system in order to make more antibodies because of reduced amounts of the actual vaccine (think of it as a booster shot for the vaccine).  The body will only make as much antibodies as it needs to fight off the infection which will require many people to get a second dose of the swine influenza vaccine, further stretching supplies.

Another problem is that the swine influenza virus is building a growing resistance to Relenza and Tamiflu vaccines.  We can only hope that the pandemic will pass and go with as little complications as possible.  However it may return in later years as a more potent mutated virulent form.  Lets pray that we have a powerful enough vaccine in sufficient enough quantities should that unfortunate event occur.  In the meantime make sure you follow standard preventative measures.

Linda Chavez – New York Post

Posted by swine flu vaccine - Google News on July 25, 2014 under Swine Flu Vaccine Information | Be the First to Comment


Town Hall
Linda Chavez
New York Post
The children come from countries that have a 93 percent vaccination rate against most childhood diseases, and given their social status in families able to afford the thousands of dollars in fees to transport them north, they're very likely to be among
Stop the fear mongering on border security and illegal immigrationWashington Examiner

all 4 news articles »

City is at the forefront of disease prevention – Oxford Mail

Posted by swine flu vaccine - Google News on under Swine Flu Vaccine Information | Be the First to Comment


Oxford Mail
City is at the forefront of disease prevention
Oxford Mail
Of the meningitis B vaccination trial he said: “That is a really considerable achievement and we feel very proud to be have been involved in the vaccination's development.” The centre was also involved in trials of two vaccines for swine flu in 2009

and more »

Flu tells its story in new film – Imperial College London

Posted by swine flu vaccine - Google News on under Swine Flu Vaccine Information | Be the First to Comment

Flu tells its story in new film
Imperial College London
'How to catch flu' was produced as part of the MOSAIC (Mechanisms of Severe Acute Influenza Consortium) project, which was launched in 2009 in the midst of the H1N1 (swine flu) pandemic. The project brought together an unprecedented group of 45 …

Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited … – MarketWatch

Posted by swine flu vaccine - Google News on under Swine Flu Vaccine Information | Be the First to Comment

Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited
MarketWatch
Sinovac's product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps and canine rabies. In 2009, Sinovac was the first company worldwide to receive approval

and more »

5 Questions: Soft-spoken healthcare VP to retire after 42 years – Sioux Falls Argus Leader

Posted by swine flu vaccine - Google News on under Swine Flu Vaccine Information | Be the First to Comment

5 Questions: Soft-spoken healthcare VP to retire after 42 years
Sioux Falls Argus Leader
Senger has given shots to thousands of children and stared at a gun barrel when investigating adult diseases. He's operated a hospital and sat in small rooms with governors. A 1976 photo shows one governor, Richard Kneip, receiving the swine flu